product summary
Loading...
company name :
Novus Biologicals
other brands :
IMGENEX
product type :
antibody
product name :
TLR6 Antibody (86B1153.2) - BSA Free
catalog :
NB100-56536
quantity :
0.1 mg (also 0.025 mg)
price :
409 USD
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
86B1153.2
reactivity :
human, mouse
application :
western blot, immunohistochemistry, immunocytochemistry, neutralization, flow cytometry, immunohistochemistry - paraffin section
more info or order :
Novus Biologicals product webpage
citations: 28
Published Application/Species/Sample/DilutionReference
  • western blot; human
Wong C, Cheung P, Ip W, Lam C. Intracellular signaling mechanisms regulating toll-like receptor-mediated activation of eosinophils. Am J Respir Cell Mol Biol. 2007;37:85-96 pubmed
Sato Y, Wakita A, Maeda E, Nagaki Y, Sasamori R, Kemuriyama K, et al. High TLR6 Expression Status Predicts a More Favorable Prognosis after Esophagectomy for Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma. Curr Oncol. 2023;30:4724-4735 pubmed publisher
Qiu C, Wang J, Zhu L, Cheng X, Xia B, Jin Y, et al. Improving the ex vivo expansion of human tumor-reactive CD8 + T cells by targeting toll-like receptors. Front Bioeng Biotechnol. 2022;10:1027619 pubmed publisher
Gabay Yehezkely R, Zaffryar Eilot S, Kaganovsky A, Fainshtain Malka N, Aviram R, Livneh I, et al. Intracellular Role for the Matrix-Modifying Enzyme Lox in Regulating Transcription Factor Subcellular Localization and Activity in Muscle Regeneration. Dev Cell. 2020;53:406-417.e5 pubmed publisher
Minna E, Brich S, Todoerti K, Pilotti S, Collini P, Bonaldi E, et al. Cancer Associated Fibroblasts and Senescent Thyroid Cells in the Invasive Front of Thyroid Carcinoma. Cancers (Basel). 2020;12: pubmed publisher
Treissman J, Yuan V, Baltayeva J, Le H, Castellana B, Robinson W, et al. Low oxygen enhances trophoblast column growth by potentiating differentiation of the extravillous lineage and promoting LOX activity. Development. 2020;147: pubmed publisher
Schöniger S, Gräfe H, Wipplinger M, Schoon H. Expression of Toll-like receptors 2, 4 and 6 in the equine chorioallantois. Vet Immunol Immunopathol. 2018;206:49-53 pubmed publisher
Dekker S, van Geemen D, van den Bogaerdt A, Driessen Mol A, Aikawa E, Smits A. Sheep-Specific Immunohistochemical Panel for the Evaluation of Regenerative and Inflammatory Processes in Tissue-Engineered Heart Valves. Front Cardiovasc Med. 2018;5:105 pubmed publisher
Schöniger S, Gräfe H, Schoon H. Expression of Toll-like receptors 2, 4 and 6 in different cell populations of the equine endometrium. Vet Immunol Immunopathol. 2017;185:7-13 pubmed publisher
Hua Y, Wang H, Tang L, Chen Q, Shao J, Mai H. LOX expression in primary nasopharyngeal carcinoma: correlation with prognostic parameters and outcome. Oncotarget. 2016;7:8200-7 pubmed publisher
Nilsson M, Hägglöf C, Hammarsten P, Thysell E, Stattin P, Egevad L, et al. High Lysyl Oxidase (LOX) in the Non-Malignant Prostate Epithelium Predicts a Poor Outcome in Prostate Cancer Patient Managed by Watchful Waiting. PLoS ONE. 2015;10:e0140985 pubmed publisher
Kim J, Lee G, Won Y, Lee M, Kwak J, Chun C, et al. Matrix cross-linking-mediated mechanotransduction promotes posttraumatic osteoarthritis. Proc Natl Acad Sci U S A. 2015;112:9424-9 pubmed publisher
Renkonen J, Toppila Salmi S, Joenväärä S, Mattila P, Parviainen V, Hagström J, et al. Expression of Toll-like receptors in nasal epithelium in allergic rhinitis. APMIS. 2015;123:716-25 pubmed publisher
Herchenhan A, Uhlenbrock F, Eliasson P, Weis M, Eyre D, Kadler K, et al. Lysyl Oxidase Activity Is Required for Ordered Collagen Fibrillogenesis by Tendon Cells. J Biol Chem. 2015;290:16440-50 pubmed publisher
Ruiz L, Báez Vega P, Ruiz A, Peterse D, Monteiro J, Bracero N, et al. Dysregulation of Lysyl Oxidase Expression in Lesions and Endometrium of Women With Endometriosis. Reprod Sci. 2015;22:1496-508 pubmed publisher
Lopez M, Palmer B, Lawrence D. Naïve T cells, unconventional NK and NKT cells, and highly responsive monocyte-derived macrophages characterize human cord blood. Immunobiology. 2014;219:756-65 pubmed publisher
Regan T, Nally K, Carmody R, Houston A, Shanahan F, Macsharry J, et al. Identification of TLR10 as a key mediator of the inflammatory response to Listeria monocytogenes in intestinal epithelial cells and macrophages. J Immunol. 2013;191:6084-92 pubmed publisher
Harman A, Bye C, Nasr N, Sandgren K, Kim M, Mercier S, et al. Identification of lineage relationships and novel markers of blood and skin human dendritic cells. J Immunol. 2013;190:66-79 pubmed publisher
Oberg H, Ly T, Ussat S, Meyer T, Kabelitz D, Wesch D. Differential but direct abolishment of human regulatory T cell suppressive capacity by various TLR2 ligands. J Immunol. 2010;184:4733-40 pubmed publisher
van den Berk L, Jansen B, Siebers Vermeulen K, Netea M, Latuhihin T, Bergevoet S, et al. Toll-like receptor triggering in cord blood mesenchymal stem cells. J Cell Mol Med. 2009;13:3415-26 pubmed publisher
Pietschmann K, Beetz S, Welte S, Martens I, Gruen J, Oberg H, et al. Toll-like receptor expression and function in subsets of human gammadelta T lymphocytes. Scand J Immunol. 2009;70:245-55 pubmed publisher
Pegu A, Qin S, Fallert Junecko B, Nisato R, Pepper M, Reinhart T. Human lymphatic endothelial cells express multiple functional TLRs. J Immunol. 2008;180:3399-405 pubmed
Peiser M, Koeck J, Kirschning C, Wittig B, Wanner R. Human Langerhans cells selectively activated via Toll-like receptor 2 agonists acquire migratory and CD4+T cell stimulatory capacity. J Leukoc Biol. 2008;83:1118-27 pubmed publisher
Yavuz S, Elbir Y, Tulunay A, Eksioglu Demiralp E, Direskeneli H. Differential expression of toll-like receptor 6 on granulocytes and monocytes implicates the role of microorganisms in Behcet's disease etiopathogenesis. Rheumatol Int. 2008;28:401-6 pubmed
Murciano C, Villamon E, Yáñez A, Murciano J, Mir A, O Connor J, et al. In vitro response to Candida albicans in cultures of whole human blood from young and aged donors. FEMS Immunol Med Microbiol. 2007;51:327-35 pubmed
Hajishengallis G, Tapping R, Harokopakis E, Nishiyama S, Ratti P, Schifferle R, et al. Differential interactions of fimbriae and lipopolysaccharide from Porphyromonas gingivalis with the Toll-like receptor 2-centred pattern recognition apparatus. Cell Microbiol. 2006;8:1557-70 pubmed
Ganley Leal L, Liu X, Wetzler L. Toll-like receptor 2-mediated human B cell differentiation. Clin Immunol. 2006;120:272-84 pubmed
Cognasse F, Hamzeh H, Chavarin P, Acquart S, Genin C, Garraud O. Evidence of Toll-like receptor molecules on human platelets. Immunol Cell Biol. 2005;83:196-8 pubmed
product information
master code :
NB100-56536
SKU :
NB100-56536
product name :
TLR6 Antibody (86B1153.2) - BSA Free
unit size :
0.1 mg (also 0.025 mg)
description :
The TLR6 Antibody (86B1153.2) - BSA Free from Novus is a mouse monoclonal antibody to TLR6. This antibody reacts with human,mouse. The TLR6 Antibody (86B1153.2) - BSA Free has been validated for the following applications: Flow Cytometry,Block/Neutralize,Flow Cytometry Control,IF/IHC,Immunohistochemistry,Western Blot,Immunohistochemistry-Paraffin,Flow (Cell Surface),Flow (Intracellular).
target :
TLR6
category :
Primary Antibodies
buffer :
PBS
clonality :
Monoclonal
clone :
86B1153.2
concentration :
1.0 mg/ml
conjugate :
Unconjugated
host :
Mouse
immunogen :
This antibody was developed against a synthetic peptide corresponding to amino acids 408-424 of human TRL6.
isotype :
IgG1
purity :
Protein G purified
species :
Human,Mouse
gene symbol :
TLR6
accessionNumbers :
Q9Y2C9
applications :
Flow Cytometry,Block/Neutralize,Flow Cytometry Control,IF/IHC,Immunohistochemistry,Western Blot,Immunohistochemistry-Paraffin,Flow (Cell Surface),Flow (Intracellular)
USD :
409 USD
alt names :
CD286, CD286 antigen, toll-like receptor 6
storage :
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
more info or order :
Novus Biologicals product webpage
company information
Novus Biologicals
10771 E Easter Ave
Centennial, CO 80112
novus@novusbio.com
https://www.novusbio.com
3037301950
headquarters: USA
Novus Biologicals licenses, manufactures, and markets antibodies to over 20,000 unique targets to support a wide array of research areas. Novus is built on honesty, collaboration and strong relationships and continues to provide quality tools that accelerate research. Every product is backed by our 100% guarantee.